Trial intelligence / Profile preview

Effects of Androgen Replacement Therapy on Ocular Surface in Androgen Deficiency

NCT07168265Completed

Sponsor
Neon Hospital
Start
Jan 2020
Primary completion
Aug 2020
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of testosterone in androgen deficiency (2 arms), sponsored by Neon Hospital. Primary endpoints: Tear Osmolarity at 5 months, Schirmer Test at 5 months and 7 more. Started Jan 2020; status: completed.

02

Drugs

testosterone
03

Conditions

androgen deficiency

Beyond the preview

Go deeper on NCT07168265.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07168265.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call